Immuron Ltd SEC filings IMRN

Immuron Ltd has 427 filings in SEC EDGAR's recent list, going back to Dec 21, 2016. Its latest annual report, Form 20-F, was filed on Sep 24, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on June 30.

Form Description Filed Period
3 Initial insider ownership May 14, 2026 Mar 18, 2026
3 Initial insider ownership May 14, 2026 Mar 18, 2026
3 Initial insider ownership May 4, 2026 Mar 18, 2026
3 Initial insider ownership Apr 29, 2026 Mar 18, 2026
3 Initial insider ownership Apr 29, 2026 Feb 9, 2026
3 Initial insider ownership Apr 29, 2026 Mar 18, 2026
3 Initial insider ownership Apr 29, 2026 Mar 18, 2026
3 Initial insider ownership Apr 29, 2026 Mar 18, 2026
SC 13G/A Amended ownership over 5% (passive) Jan 7, 2021 —
SC 13D Ownership over 5% (active) Aug 4, 2020 —
SC 13G Ownership over 5% (passive) Jul 21, 2020 —
SC 13G/A Amended ownership over 5% (passive) Jan 15, 2020 —
SC 13G/A Amended ownership over 5% (passive) Jan 29, 2019 —
SC 13G Ownership over 5% (passive) Mar 20, 2018 —
SC 13G Ownership over 5% (passive) Jun 22, 2017 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMRN (Nasdaq)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Carlton, Victoria, Australia
SEC filer status
Non-accelerated filer
SEC CIK
1660046

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.